Skip to content
Wenlo
Sign in
← Markets

Guardant Health, Inc.

Guardant Health, Inc. (GH) — Form 144: Proposed sale of shares

144GHFiled Nov 16, 2026, 11:52 AM ET

AI-generated summary

Director Azar Alex M II proposed to sell 207 shares of Guardant Health, Inc. common stock with an aggregate market value of $30,959 through Charles Schwab & Co., Inc. The shares were acquired via restricted stock lapse on November 12, 2026. The proposed sale is associated with a trading plan adopted on May 21, 2026.

Key facts

Seller
Azar Alex M II
Relationship
Director
Shares to sell
207
Market value
$30,959.00
Approximate sale date
Nov 16, 2026
Broker
Charles Schwab & Co., Inc.
Acquired
Nov 12, 2026 · Restricted Stock Lapse - See Remarks

Rule 10b5-1 plan · adopted May 21, 2026

Remarks
  1. Shares on this filing may be sold and acquired over various dates.

More GH filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.